Cardinal Health, Inc. with ticker code (CAH) have now 15 analysts in total covering the stock. The consensus rating is pointing to ‘buy’. The target price High/Low ranges between $140.00 and $101.00 calculating the mean target price we have $118.28. Given that the stocks previous close was at $109.79 this indicates there is a potential upside of 7.7%. The day 50 moving average is $107.06 and the 200 day MA is $104.56. The market cap for the company is 26.74B. The price for the stock stands currently at: $110.52 USD
The potential market cap would be $28,809,555,340 based on the market consensus.
The company is not paying dividends at this time.
Other points of data to note are a P/E ratio of 32.03, revenue per share of $925.82 and a 3.03% return on assets.
Cardinal Health, Inc. is a globally integrated healthcare services and products company. The Company is focused on providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices and patients in the home. The Company also provides pharmaceuticals and medical products and solutions. The Company’s segments include Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical and over-the-counter healthcare and consumer products in the United States. The Medical segment manufactures, sources and distributes Cardinal Health branded medical, surgical and laboratory products, which are sold in the United States, Canada, Europe, Asia and other markets. The Company connects patients, providers, payers, pharmacists and manufacturers for integrated care coordination and patient management.
